Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Polycystic Ovary Syndrome 1Lymphoma, Follicular 1Diabetes Mellitus, Type 2 1Dementia 1Cognitive Dysfunction 1

Interventions

mazdutide 1lithium sulfate 1lime 1fasudil 1blueberry extract 1Walking 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Therapeutics 1Tablets 1Radiotherapy 1Patient Reported Outcome Measures 1Organization and Administration 1Neuropsychological Tests 1Modafinil 1Methods 1Metformin 1Memantine 1Low-Level Light Therapy 1Lithium 1Infliximab 1Drug Therapy 1Data Collection 1Cognitive Behavioral Therapy 1Chemoradiotherapy 1Accidental Falls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cognitive Dysfunction × mazdutide × Clear all
NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 3 Recruiting
420 enrolled
Lymphoid

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡